ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
By J. Sterne, Miguel A. Hern'an, B. Reeves, J. Savović, N. Berkman, M. Viswanathan, David Henry, Douglas G. Altman, M. Ansari, I. Boutron and 25 more. British medical journal, 2016
17,786 citations recorded by the source corpus.
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
Subfields: Economics and Econometrics, General Health Professions, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/d9cd82f89ce2410b6ed9e2367cbaec8e8724aaa5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Gary S. Collins
- Johannes B Reitsma
- Karel G. M. Moons
- David Moher
- Patrick M. M. Bossuyt
- R. Riley
- I. Boutron
- Matthew J. Page
In General Health Professions
- Gary S. Collins
- Johannes B Reitsma
- David Moher
- Karel G. M. Moons
- Matthew J. Page
- Larissa Shamseer
- Patrick M. M. Bossuyt
- L. Stewart
In Statistics and Probability
- David Moher
- Douglas G. Altman
- Gary S. Collins
- Matthew J. Page
- Johannes B Reitsma
- Karel G. M. Moons
- R. Riley
- Patrick M. M. Bossuyt
Citations in the corpus
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021, methodology): “For example, technological advances have enabled the use of natural language processing and machine learning to identify relevant evidence,[22–24] methods have been proposed to synthesise and present findings when meta-analysis is not possible or appropriate,[25–27] and new methods have been develop”
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis (2020, neutral): “32”
- A step by step guide for conducting a systematic review and meta-analysis with simulation data (2019, methodology): “A variety of tools are available for the QA, depending on the design: ROB-2 Cochrane tool for randomized controlled trials [18] which is presented as Additional file 1: Figure S1 and Additional file 2: Figure S2 -from a previous published article data- [19] , NIH tool for observational and cross-sec”
- Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report (2012, methodology): “The Cochrane Risk of Bias tool was used to assess the risk of bias for randomized controlled trials (RCTs)(5) and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool to evaluate risk of bias for observational studies.(6) In cases in which existing systematic reviews were avail”
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. (2021, methodology): “For example, technological advances have enabled the use of natural language processing and machine learning to identify relevant evidence [22–24] , methods have been proposed to synthesise and present findings when meta-analysis is not possible or appropriate [25–27] , and new methods have been dev”
- Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis (2020, methodology): “RoB 2’ for randomized trials [18] and with ‘ROBINS-I’ used for observational studies [19], for sepsis and septic shock, 30 and 90 days mortality each.”
- Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults (2017, methodology): “ofBias inNon-randomizedStudiesof Interventions (ROBINS-I) tool, which considers biases from confounding, selection of participants into the studies,missing data, andmeasurement of outcomes.(16)Two investigators (S.”